Mereo BioPharma Group Statistics
NASDAQ: MREOHealth CareBiotechnology: Pharmaceutical PreparationsUSD
0.3556-0.0196 (-5.22%)
Market open · Delayed 15 min · as of Oct 9, 2:23 PM ET
Mereo BioPharma Group by the numbers
Mereo BioPharma Group has a market capitalization of $56.8 million based on 159.69M shares outstanding. With trailing EPS of $-0.20, Mereo BioPharma Group is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 15.5% above its 50-day average and 7.3% below its 200-day average.
Average daily trading volume is 4.04M shares, or about $1.4 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
MREO valuation vs. peer median
| Metric | MREO | Peer median | Difference |
|---|---|---|---|
| Market cap | $56.79M | $58.52M | -3% |
| Avg. volume | 4.04M | 428.17K | +843% |
Peer median across 8 companies: XLO, GOSS, RNXT, CNTB, BOLD, APLM, IBIO, PLRX.
Valuation
- Market cap
- $56.79M
- EPS (TTM)
- $-0.20
- Shares outstanding
- 159.69M
Price and trading
- Previous close
- 0.3752
- Open
- 0.38
- Day range
- 0.3516 – 0.3883
- 52-week range
- 0.20 – 2.37
- 52-week change
- -80.86%
- 50-day moving average
- 0.3079
- 200-day moving average
- 0.3836
- Beta
- —
- Volume
- 732.14K
- Average volume
- 4.04M
Dividends and events
- Annual dividend
- None
- Next earnings date
- Aug 11, 2026
Additional statistics
- Market Cap
- 56.79M
- Forward Pe
- -15.53
- Eps
- -0.20
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 2.37
- Week52 Low
- 0.20
- Avg Volume
- 4.04M
- Shares Outstanding
- 159.69M
- Ma50
- 0.31
- Ma200
- 0.38
- Earnings Date
- Aug 11, 2026
- Pct From52w High
- -85.00%
- Pct From52w Low
- 77.80%